Creatinine-cystatin C ratio and mortality in cancer patients: a retrospective cohort study.

ABSTRACT:

Background

Muscle wasting is prevalent in cancer patients, and early recognition of this phenomenon is important for risk stratification. Recent studies have suggested that the creatinine-cystatin C ratio may correlate with muscle mass in several patient populations. The association between creatinine-cystatin C ratio and survival was assessed in cancer patients.

Methods

A total of 3060 patients who were evaluated for serum creatinine and cystatin C levels at the time of cancer diagnosis were included. The primary outcome was 6-month mortality. The 1-year mortality, and length of intensive care unit (ICU) and hospital stay were also evaluated.

Results

The mean age was 61.6 ± 13.5 years, and 1409 patients (46.0%) were female. The median creatinine and cystatin C levels

SUBMITTER: Jung CY 

PROVIDER: S-EPMC9397493 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature